Select Medical (NYSE:SEM) Stock Rating Lowered by StockNews.com

Select Medical (NYSE:SEM) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Thursday.

A number of other research firms also recently commented on SEM. Royal Bank of Canada increased their target price on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Benchmark reiterated a “buy” rating and set a $48.00 price objective on shares of Select Medical in a research report on Friday, November 1st. Finally, Bank of America assumed coverage on shares of Select Medical in a report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 target price on the stock. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $40.75.

Select Medical Trading Up 1.5 %

Shares of SEM opened at $39.67 on Thursday. Select Medical has a 1 year low of $22.26 and a 1 year high of $40.98. The company has a 50 day simple moving average of $35.10 and a two-hundred day simple moving average of $34.97. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The firm has a market cap of $5.14 billion, a P/E ratio of 18.16, a price-to-earnings-growth ratio of 1.66 and a beta of 1.42.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the previous year, the firm posted $0.46 EPS. Select Medical’s revenue for the quarter was up 5.7% compared to the same quarter last year. On average, equities analysts expect that Select Medical will post 2.16 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Select Medical

Several hedge funds have recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its stake in Select Medical by 16.6% in the third quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock worth $81,000 after purchasing an additional 330 shares during the last quarter. Foster & Motley Inc. boosted its holdings in Select Medical by 3.1% during the 2nd quarter. Foster & Motley Inc. now owns 12,147 shares of the health services provider’s stock valued at $426,000 after acquiring an additional 370 shares during the period. KBC Group NV grew its position in Select Medical by 4.5% in the 3rd quarter. KBC Group NV now owns 13,050 shares of the health services provider’s stock valued at $455,000 after acquiring an additional 563 shares during the last quarter. Arizona State Retirement System increased its stake in Select Medical by 2.0% in the second quarter. Arizona State Retirement System now owns 30,544 shares of the health services provider’s stock worth $1,071,000 after purchasing an additional 593 shares during the period. Finally, Hexagon Capital Partners LLC boosted its stake in shares of Select Medical by 528.7% during the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 645 shares during the period. 89.48% of the stock is currently owned by institutional investors.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.